In this episode, OMA Chief Science Officer, Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC interviews Laura Davisson, MD, MPH, FACP, to discuss a recent article on the comparison of Metformin and lifestyle intervention in diabetes prevention. Topics covered include the success of the intensive lifestyle intervention of the Diabetes Prevention Program, the difficulty many patients have with weight loss maintenance, and the consideration of prescribing Metformin for prediabetes.
In our article review podcasts, we have carefully selected recent articles included in the latest version of the Obesity Medicine Association (OMA) Obesity Algorithm, which is a comprehensive review of obesity medicine that can be found at obesitymedicine.org. We then discuss this new science with obesity experts. To access other resources from the clinical leader in Obesity Medicine, visit: www.obesitymedicine.org.
Episode Guests
Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
Resources Mentioned
In this episode, Dr. Harold Bays and Dr. Carolynn Francavilla discuss their experience with prior authorizations for obesity medications including the highly effective GLP-1...
Episode Description In our article review podcasts, we have carefully selected recent articles included in the latest version of the OMA Obesity Algorithm. We...
In this episode, Obesity medicine specialist and OMA clinical education director Dr. Nicholas Pennings interviews Dr. Sylvia Gonsahn-Bollie about the role of BMI in...